Total Payments
$5,102
2024 Payments
$86.22
Companies
21
Transactions
145
Medicare Patients
3,749
Medicare Billing
$656,350
Payment Breakdown by Category
Food & Beverage$3,329 (65.2%)
Travel$1,333 (26.1%)
Education$439.96 (8.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,329 | 128 | 65.2% |
| Travel and Lodging | $1,333 | 8 | 26.1% |
| Education | $439.96 | 9 | 8.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $1,791 | 24 | $0 (2023) |
| Janssen Biotech, Inc. | $577.34 | 19 | $0 (2024) |
| UROVANT SCIENCES INC | $550.79 | 26 | $0 (2022) |
| ABBVIE INC. | $411.01 | 12 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $311.51 | 8 | $0 (2023) |
| Astellas Pharma US Inc | $311.14 | 12 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $251.49 | 4 | $0 (2022) |
| TOLMAR Pharmaceuticals, Inc. | $166.24 | 9 | $0 (2022) |
| Teleflex LLC | $138.74 | 1 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $124.65 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $86.22 | 4 | Janssen Biotech, Inc. ($86.22) |
| 2023 | $564.26 | 24 | ABBVIE INC. ($214.46) |
| 2022 | $3,291 | 94 | Medtronic, Inc. ($1,232) |
| 2021 | $1,161 | 23 | Medtronic, Inc. ($527.63) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/16/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Oncology | ||||||
| 03/14/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Oncology | ||||||
| 01/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Oncology | ||||||
| 01/03/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: Oncology | ||||||
| 11/01/2023 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: Oncology | ||||||
| 10/11/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Oncology | ||||||
| 09/27/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Oncology | ||||||
| 09/20/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Oncology | ||||||
| 04/28/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.21 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2023 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | Cash or cash equivalent | $13.85 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/21/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Urology | ||||||
| 03/06/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: HORMONE THERAPY | ||||||
| 03/01/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Oncology | ||||||
| 02/27/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 02/25/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Urology | ||||||
| 02/23/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $107.10 | General |
| Category: UROLOGY | ||||||
| 02/22/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/18/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Urology | ||||||
| 02/15/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Oncology | ||||||
| 02/10/2023 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Oncology | ||||||
| 02/07/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/01/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Urology | ||||||
| 02/01/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Sacral Nerve Stimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,253 | 8,432 | $810,366 | $275,439 |
| 2022 | 22 | 1,499 | 12,941 | $778,992 | $266,154 |
| 2021 | 16 | 997 | 3,245 | $363,762 | $114,757 |
Total Patients
3,749
Total Services
24,618
Medicare Billing
$656,350
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 396 | 1,571 | $354,261 | $121,843 | 34.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 175 | 898 | $141,920 | $49,014 | 34.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 19 | 2,400 | $84,000 | $42,877 | 51.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 181 | 203 | $57,278 | $19,695 | 34.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 23 | 109 | $46,325 | $14,800 | 31.9% |
| J9155 | Injection, degarelix, 1 mg | Office | 2023 | 13 | 2,720 | $21,760 | $7,809 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 136 | $36,110 | $5,761 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 38 | $11,437 | $3,095 | 27.1% |
| 64566 | Insertion of lower leg neurostimulator electrode | Office | 2023 | 13 | 38 | $22,420 | $2,722 | 12.1% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 16 | 18 | $6,756 | $2,361 | 35.0% |
| 51705 | Simple change of bladder tube | Office | 2023 | 15 | 26 | $5,590 | $1,521 | 27.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $5,975 | $1,171 | 19.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 33 | 50 | $7,000 | $968.27 | 13.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $3,915 | $822.10 | 21.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 40 | 43 | $2,623 | $323.68 | 12.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 38 | $681.00 | $306.46 | 45.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 87 | 98 | $490.00 | $215.60 | 44.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 16 | $1,824 | $134.55 | 7.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 29 | 6,660 | $233,100 | $113,938 | 48.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 43 | 376 | $159,800 | $51,960 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 398 | 592 | $157,472 | $36,458 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 135 | 150 | $45,150 | $12,949 | 28.7% |
| J9155 | Injection, degarelix, 1 mg | Office | 2022 | 15 | 3,920 | $31,360 | $12,358 | 39.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $24,800 | $7,299 | 29.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 55 | 55 | $14,355 | $4,296 | 29.9% |
About Devora Singer, CRNP
Devora Singer, CRNP is a Home Health healthcare provider based in Cumberland, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1770827974.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Devora Singer, CRNP has received a total of $5,102 in payments from pharmaceutical and medical device companies, with $86.22 received in 2024. These payments were reported across 145 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,329).
As a Medicare-enrolled provider, Singer has provided services to 3,749 Medicare beneficiaries, totaling 24,618 services with total Medicare billing of $656,350. Data is available for 3 years (2021–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Home Health
- Other Specialties Family
- Location Cumberland, MD
- Active Since 11/12/2012
- Last Updated 01/22/2025
- Taxonomy Code 163WH0200X
- Entity Type Individual
- NPI Number 1770827974
Products in Payments
- INTERSTIM (Device) $1,791
- GEMTESA (Drug) $653.88
- ERLEADA (Drug) $577.34
- BOTOX (Biological) $389.46
- PROVENGE (Drug) $251.49
- Nubeqa (Drug) $174.13
- ELIGARD (Drug) $166.24
- UROLIFT (Device) $138.74
- Xofigo (Drug) $137.38
- KEYTRUDA (Biological) $102.23
- Myrbetriq (Drug) $89.62
- ORGOVYX (Drug) $60.17
- UBRELVY (Drug) $45.61
- XTANDI (Drug) $44.94
- PREMARIN (Drug) $44.03
- GENTLECATH (Device) $43.59
- XGEVA (Biological) $36.56
- GentleCath (Device) $26.04
- LUPRON DEPOT (Drug) $20.86
- FOUNDATIONONE (Device) $20.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.